No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali

American Journal of Tropical Medicine and Hygiene

Volumn 87, Issue 1, 2012, Pages 23-28

  Maiga, Amelia W ^b   Fofana, Bakary ^a   Sagara, Issaka ^a   Dembele, Demba ^a   Dara, Antoine ^a   Traore, Oumar Bila ^a   Toure, Sekou ^a   Sanogo, Kassim ^a   Dama, Souleymane ^a   Sidibe, Bakary ^a   Kone, Aminatou ^a   Thera, Mahamadou A ^a   Plowe, Christopher V ^c   Doumbo, Ogobara K ^a   Djimde, Abdoulaye A ^a  

^a UNIVERSITY OF BAMAKO   (Mali)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Maryland School of Medicine Center for Vaccine Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ASUNATE DENK; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SMEAR; CHILD; CONTROLLED STUDY; DISEASE RESISTANCE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; INFANT; MALARIA FALCIPARUM; MALE; MALI; MICROSCOPY; PARASITE CLEARANCE; PARASITEMIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RURAL POPULATION; SCHOOL CHILD; SINGLE DRUG DOSE;

ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MALI; PARASITEMIA;

ARTESUNATE; PLASMODIUM FALCIPARUM;

EID: 84863743157     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.12-0058     Document Type: Article

References (28)

1. WHO, 2010. Guidelines for the Treatment of Malaria. Geneva: World Health Organization.
2. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, Day NP, White NJ, White LJ, 2009. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J 8: 31.
3. AlkerAP, Lim P, Sem R, Shah NK, Yi P, BouthDM, Tsuyuoka R, Maguire JD, Fandeur T, Ariey F, Wongsrichanalai C, Meshnick SR, 2007. Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg 76: 641-647. (Pubitemid 351627700)
4. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359: 2619-2620.
5. Imwong M, Dondorp AM, Nosten F, Yi P, Mungthin M, Hanchana S, Das D, Phyo AP, Lwin KM, Pukrittayakamee S, Lee SJ, Saisung S, Koecharoen K, Nguon C, Day NP, Socheat D, White NJ, 2010. Exploring the contribution of candidate genes to artemisinin resistance in Plasmodium falciparum. Antimicrob Agents Chemother 54: 2886-2892.
6. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
7. WHO, 2010. Global Report on AntimalarialDrug Efficacy andDrug Resistance: 2000-2010. Geneva: World Health Organization.
8. Djimde AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, Dama S, Ouologuem D, Dicko A, Doumbo OK, 2008. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. Am J Trop Med Hyg 78: 455-461. (Pubitemid 351845197)
9. WHO, 2003. Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. Geneva: World Health Organization.
10. 2000. Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 94 (Suppl 1): S1-S90.
11. von Seidlein L, Drakeley C, Greenwood B, Walraven G, Targett G, 2001. Risk factors for gametocyte carriage in Gambian children. Am J Trop Med Hyg 65: 523-527. (Pubitemid 33134586)
12. Beshir KB, Hallett RL, Eziefula AC, Bailey R, Watson J, Wright SG, Chiodini PL, Polley SD, Sutherland CJ, 2010. Measuring the efficacy of anti-malarial drugs in vivo: quantitative PCR measurement of parasite clearance. Malar J 9: 312.
13. Flegg J, Guerin P, White N, Stepniewska K, 2011. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J 10: 339.
14. WHO, 2009. Methods for Surveillance of Antimalarial Drug Efficacy. Geneva: World Health Organization.
15. Stepniewska K, Ashley E, Lee SJ, Anstey N, Barnes KI, Binh TQ, D'Alessandro U, Day NP, de Vries PJ, Dorsey G, Guthmann JP, Mayxay M, Newton PN, Olliaro P, Osorio L, Price RN, Rowland M, Smithuis F, Taylor WR, Nosten F, White NJ, 2010. In vivo parasitological measures of artemisinin susceptibility. J Infect Dis 201: 570-579.
16. Carrara VI, Zwang J, Ashley EA, Price RN, Stepniewska K, Barends M, Brockman A, Anderson T, McGready R, Phaiphun L, Proux S, van Vugt M, Hutagalung R, Lwin KM, Phyo AP, Preechapornkul P, Imwong M, Pukrittayakamee S, Singhasivanon P, White NJ, Nosten F, 2009. Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment. PLoS ONE 4: e4551.
17. Ittarat W, Pickard AL, Rattanasinganchan P, Wilairatana P, Looareesuwan S, Emery K, Low J, Udomsangpetch R, Meshnick SR, 2003. Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. Am J Trop Med Hyg 68: 147-152. (Pubitemid 38240537)
18. Sowunmi A, Adewoye EO, Gbotsho GO, Happi CT, Sijuade A, Folarin OA, Okuboyejo TM, Michael OS, 2010. Factors contributing to delay in parasite clearance in uncomplicated falciparum malaria in children. Malar J 9: 53.
19. Brandts CH, Ndjave M, Graninger W, Kremsner PG, 1997. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria. Lancet 350: 704-709. (Pubitemid 27371169)
20. Michael OS, Gbotosho GO, Folarin OA, Okuboyejo T, Sowunmi A, Oduola AM, Happi CT, 2010. Early variations in Plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance. Malar J 9: 335.
21. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, Darapiseth S, Teja-Isavadharm P, Khemawoot P, Schaecher K, Ruttvisutinunt W, Lin J, Kuntawungin W, Gosi P, Timmermans A, Smith B, Socheat D, Fukuda MM, 2011. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS ONE 6: e19283.
22. Yeung S, Van Damme W, Socheat D, White N, Mills A, 2008. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J 7: 96.
23. Nyunt MM, Plowe CV, 2007. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Clin Pharmacol Ther 82: 601-605. (Pubitemid 47622531)
24. Thanh NV, Toan TQ, Cowman AF, Casey GJ, Phuc BQ, Tien NT, Hung NM, Biggs BA, 2010. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009. Malar J 9: 181.
25. White NJ, 2011. The parasite clearance curve. Malar J 10: 278.
26. Giao PT, Binh TQ, Kager PA, Long HP, Van Thang N, Van Nam N, de Vries PJ, 2001. Artemisinin for treatment of uncomplicated falciparum malaria: is there a place for monotherapy? Am J Trop Med Hyg 65: 690-695. (Pubitemid 34049457)
27. WHO, 2011. Global Plan for Artemisinin Resistance Containment. Geneva: World Health Organization.
28. Plowe CV, 2009. The evolution of drug-resistant malaria. Trans R Soc Trop Med Hyg 103 (Suppl 1): S11-S14.